DBV Technologies

Food allergy biotech DBV is running out of cash, with phase 3 trials underway
Fierce Biotech
Fri, 03/8/24 - 11:32 am
DBV Technologies
food allergies
earnings
clinical trials
peanut allergy
FDA slaps hold on DBV peanut allergy trial in call for protocol changes
Fierce Biotech
Thu, 09/22/22 - 10:33 am
DBV Technologies
clinical trials
FDA
peanut allergy
DBV patches up prospects with phase 3 win in infants with peanut allergies
Fierce Biotech
Wed, 06/8/22 - 10:15 am
DBV Technologies
peanut allergy
clinical trials
infants
The biotech resurrection continues
EP Vantage
Fri, 01/15/21 - 10:39 am
biotech
Lexicon Pharmaceuticals
DBV Technologies
Pfizer
Trillium Therapeutics
DBV restructuring claims 200 jobs as it beats out a path toward peanut patch OK
Endpoints
Thu, 01/7/21 - 11:21 pm
DBV Technologies
peanut allergy
Viaskin Peanut
layoffs
Why DBV Technologies Stock Is Soaring Today
Motley Fool
Mon, 11/2/20 - 11:04 pm
DBV Technologies
Viaskin Peanut
peanut allergy
Europe
EMA
Viaskin™ Peanut’s Long-Term Phase III Updates and What the FDA Has to Say About Them
BioSpace
Fri, 08/14/20 - 11:03 am
DBV Technologies
Viaskin Peanut
peanut allergy
FDA
FDA turns back DBV Technologies’ peanut allergy patch, raising questions about its design
Fierce Biotech
Tue, 08/4/20 - 01:07 pm
DBV Technologies
FDA
Viaskin Peanut
With Peanut Patch in FDA Purgatory, DBV Plans Layoffs to Stretch Cash
Xconomy
Fri, 06/26/20 - 07:50 pm
DBV Technologies
FDA
peanut allergy
layoffs
Viaskin Peanut
A Tale of 2 Biotechs With Competing Peanut Allergy Treatments
Motley Fool
Thu, 04/16/20 - 11:43 pm
peanut allergy
Viaskin Peanut
DBV Technologies
Aimmune Therapeutics
Palforzia
In another win for rival Aimmune, FDA presses pause on DBV's peanut patch with additional questions
Endpoints
Tue, 03/17/20 - 12:01 pm
FDA
Aimmune
DBV Technologies
peanut allergy
Viaskin Peanut
DBV's peanut prevention patch approaches key stage of approval process
Endpoints
Fri, 02/21/20 - 10:27 am
DBV Technologies
peanut allergy
FDA
drug approvals
Viaskin Peanut
What Aimmune's Peanut Allergy Drug Approval Means for the Rest of the Pipeline
Motley Fool
Wed, 02/5/20 - 10:14 am
Aimmune
FDA
peanut allergy
Palfozia
DBV Technologies
FDA decision nears on Aimmune's contested peanut allergy drug
BioPharma Dive
Fri, 01/24/20 - 12:07 pm
FDA
Aimmune
peanut allergy
Palforzia
DBV Technologies
Viaskin Peanut
DBV Technologies announces FDA acceptance of BLA filing for Viaskin Peanut to treat peanut allergy
Pharmaceutical Business Review
Mon, 10/7/19 - 10:58 am
Viaskin Peanut
DBV Technologies
FDA
peanut allergy
DBV Technologies Resubmits BLA for Peanut Allergy Treatment
BioSpace
Thu, 08/8/19 - 11:52 pm
DBV Technologies
FDA
peanut allergy
Viaskin Peanut
New peanut allergy therapies aren’t as effective — or nearly as inexpensive — as abstinence, says ICER
Endpoints
Thu, 07/11/19 - 12:03 pm
peanut allergy
Aimmune Therapeutics
DBV Technologies
ICER
AR101
Viaskin Peanut
DBV Rejoins Peanut Allergy Treatment Race, But Aimmune Takes the Lead
Xconomy
Thu, 02/14/19 - 12:08 am
DBV Technologies
Aimmune
peanut allergy
AR-101
Viaskin Peanut
DBV Technologies pulls peanut allergy treatment from FDA review
Stat
Thu, 12/20/18 - 12:13 am
DBV Technologies
peanut allergy
FDA
Viaskin Peanut
DBV climbs as messy milk allergy data open door to phase 3
Fierce Biotech
Tue, 02/27/18 - 06:53 pm
DBV Technologies
food allergies
milk allergy
Viaskin Milk

Pages